03:18 AM EST, 11/14/2024 (MT Newswires) -- James E Flynn, 10% Owner, on November 11, 2024, sold 563,270 shares in ARS Pharmaceuticals ( SPRY ) for $10,143,706. Following the Form 4 filing with the SEC, Flynn has control over a total of 5,257,328 shares of the company, with 5,257,328 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1671858/000119380524001348/xslF345X05/e664025_4-arsp.xml